NCT04030754 is a Phase 2, PHASE3 clinical trial of amniotic membrane in Burns, sponsored by King Edward Medical University.

Who is sponsoring NCT04030754?

NCT04030754 is sponsored by King Edward Medical University.

What drugs are being tested in NCT04030754?

Interventions in NCT04030754: amniotic membrane, duoderm dressing.

Is NCT04030754 still recruiting?

NCT04030754 is currently completed. Last updated 1 September 2020.

Last reviewed 2020-09-01 · How we verify

NCT04030754

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Effectiveness of Amniotic Membrane and Duoderm Dressings in Pediatric Burns

Completed Phase 2, PHASE3 Last updated 1 September 2020

What this trial tests

Phase 2, PHASE3 trial testing amniotic membrane in Burns in 172 participants. Completed in 14 February 2020.

Timeline

1 November 2018

Primary endpoint
14 February 2020

14 February 2020

Quick facts

Lead sponsor	King Edward Medical University
Phase	Phase 2, PHASE3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	172
Start date	1 November 2018
Primary completion	14 February 2020
Estimated completion	14 February 2020
Sites	1 location across Pakistan

Drugs / interventions tested

amniotic membrane — full drug profile →
duoderm dressing

Conditions studied

Burns — all drugs for Burns →

Sponsor

King Edward Medical University

Who can join

Adults 1 to 12, any sex, with Burns. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is a difference in frequency of wound infection, mean pain score, mean of time for skin grafting and hospital stay in pediatric 2nd and 3rd degree burns, between amniotic membrane and duoderm dressings

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of amniotic membrane

Trials testing the same drug.

NCT07219004 — Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers. · NA · completed

Other recruiting trials for Burns

Currently open trials in the same condition.

NCT07259668 — Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Thermal Burns · recruiting
NCT07248930 — Lipopolysaccharide Adsorption (Efferon LPS NEO) in Children With Thermal Burns · recruiting
NCT07313735 — The Effect of Cartoon Character-Printed Band Use During Burn Dressing on Fear, Stress, Pain, and Physiological Parameter · NA · recruiting
NCT07142824 — Comparison Between Burn Dressing Using Tilapia-Fish Skin Versus Regular Dressing · NA · recruiting
NCT07277166 — The Effect of Mobile Robot Assisted Gait Training on Gait Performance in Chronic Patients With Impaired Gait Function Af · NA · recruiting

Other King Edward Medical University trials

Trials by the same sponsor.

NCT07480447 — Comparison of Pain Reduction in Painful Chronic Wounds With and Without Fat Grafting · NA · not yet recruiting
NCT07428265 — Comparison of Wound Healing for Diabetic Carbuncle Treated With Incision and Drainage Technique Using Cruciate Incision · NA · recruiting
NCT07368439 — Effect of Feedback-Based Balance Training on Balance and Gait in Cancer Patients With Chemotherapy-Induced Peripheral Ne · NA · not yet recruiting
NCT07210424 — Comparative Study on the Post-operative Pain and Other Outcomes of Mesh Fixation With Prolene vs Vicryl vs Skin Staples · not yet recruiting
NCT07267260 — Evaluating the Efficacy of Vonoprazan in Preventing Post-Endoscopic Variceal Band Ligation Ulcers: A Randomized Controll · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04030754 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by King Edward Medical University
Last refreshed: 1 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04030754.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing